$663 Million is the total value of Sands Capital Ventures, LLC's 13 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PATH | New | UIPATH INC | $200,538,000 | – | 3,811,779 | +100.0% | 30.24% | – |
| DASH | New | DOORDASH INC | $129,812,000 | – | 630,217 | +100.0% | 19.57% | – |
| New | DICE THERAPEUTICS, INC. | $103,129,000 | – | 3,148,970 | +100.0% | 15.55% | – | |
| SNOW | New | SNOWFLAKE INC | $95,742,000 | – | 316,576 | +100.0% | 14.44% | – |
| ABOS | New | ACUMEN PHARMACEUTICALS, INC | $50,778,000 | – | 3,417,075 | +100.0% | 7.66% | – |
| KRTX | New | KARUNA THERAPEUTICS, INC. | $32,772,000 | – | 267,895 | +100.0% | 4.94% | – |
| TSHA | New | TAYSHA GENE THERAPIES INC | $13,497,000 | – | 724,873 | +100.0% | 2.04% | – |
| MASS | New | 908 DEVICES INC | $10,615,000 | – | 326,427 | +100.0% | 1.60% | – |
| New | CANDEL THERAPEUTICS, INC | $8,799,000 | – | 811,737 | +100.0% | 1.33% | – | |
| RGEN | New | REPLIGEN CORP. | $6,515,000 | – | 22,544 | +100.0% | 0.98% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $5,603,000 | – | 260,000 | +100.0% | 0.84% | – |
| SPRB | New | SPRUCE BIOSCIENCES INC | $4,730,000 | – | 787,007 | +100.0% | 0.71% | – |
| New | ABSCI CORP. | $672,000 | – | 57,804 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UIPATH INC | 9 | Q3 2023 | 30.2% |
| DOORDASH INC | 9 | Q3 2023 | 19.6% |
| SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
| ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
| 908 DEVICES INC | 9 | Q3 2023 | 1.8% |
| TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
| TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
| CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
| SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
| ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.